Stem cell gene therapy - search results

Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells

Manuela Côrte-Real outlines how yeast can clarify the regulation of cell death pathways and provide new therapeutic strategies for human diseases

Dr. Franz E. Weber, University Zurich's Center of Dental Medicine discusses how personalised medicine can be used in bone regeneration.

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

A new class of nanotherapy blockades the genetic drive for multiple myeloma progression. Gregory M. Lanza and Michael H Tomasson, of Department of Medicine, Washington University School of Medicine explain... Multiple myeloma is malignancy of plasma cells that reside in the bone marrow and normally function as part of our immune defence...

Professor Wen Jiang, Dr Andrew Sanders and Dr Lin Ye from the Cardiff China Medical Research Collaborative, Cardiff University School of Medicine highlight the work being done to combat cancer and develop new treatments… Cancer presents a serious issue worldwide for healthcare systems and results in substantial morbidity and mortality for...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute at Cardiff University, outlines the aim to develop more personalised therapies for patients with cancer and how targeting the cancer stem cell could be crucial in this development. Cancer remains the second largest cause of death in the western...

Claire Bale, Communications Manager for Parkinson’s UK, highlights the latest thinking in stem cell research for the potential treatment of Parkinson’s. Stem cells can develop into almost any cell in the body. They are the original cells from which we are made, and are responsible for repairing our tissues and...

Regenerative medicine and cell therapy can revolutionise healthcare. Kath Mackay and Michael Sullivan, Lead Technologists in Regenerative Medicine at the Technology Strategy Board outline the importance of the field. Innovation is essential in developing the next generation of medical treatments. As the global population grows and ages, healthcare providers will need...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute gives an overview of how cancer stem cells differ from the conventional stem cell. Cancer remains one of the major challenges in terms of life expectancy and is recognised as the second largest cause of mortality within the...

Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute gives an overview of how cancer stem cells differ from the conventional stem cell. Cancer remains one of the major challenges in terms of life expectancy and is recognised as the second largest cause of mortality within the...

From stem cell biology to tissue mending In the last 25 years, tremendous advances have been made in the identification and generation of stem cells (SC) from diverse organisms, generating a wealth of knowledge in various fields from embryology to development. SC not only have the ability to differentiate into...

In this second interview, Professor Dr Martin Flück reveals how his research aims to shed light on the mechanisms that govern skeletal muscle function in health and disease, with the goal of translating the findings into more effective clinical applications.

Taking steps to protect our hearing often falls low on people’s agenda, but hearing loss can have serious lifelong consequences.

Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.

Ashley V. Makela and Christopher H. Contag from the Institute for Quantitative Health Science and Engineering, walk us through watching living therapeutics in action, including what imaging reveals about engineered endosymbionts.

Dr Deborah Lee of Dr Fox Online Pharmacy outlines the burden of osteoarthritis, how it can impact daily life, and emerging treatment options.

In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.

Two seasoned experts from CPI, Medicines Manufacturing Innovation Centre, detail how the “tides” have turned in pharma manufacturing.

Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.